José Ignacio
Herrero Santos
Consultor Médico
Hospital Universitario La Paz
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario La Paz (7)
2017
-
Effectiveness and safety of ombitasvir, paritaprevir, ritonavir ± dasabuvir ± ribavirin: An early access programme for Spanish patients with genotype 1/4 chronic hepatitis C virus infection
Journal of Viral Hepatitis, Vol. 24, Núm. 3, pp. 226-237
-
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registry
Hepatology, Vol. 65, Núm. 6, pp. 1810-1822
2016
-
Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma
Hepatology, Vol. 63, Núm. 2, pp. 488-498
2015
-
Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey
Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9
-
V Reunión de Consenso de la Sociedad Española de Trasplante Hepático sobre receptores de riesgo elevado, escenarios actuales de inmunosupresión y manejo del hepatocarcinoma en espera de trasplante
Cirugia Espanola, Vol. 93, Núm. 10, pp. 619-637
2014
-
The impact of the prevention strategies on the indirect effects of CMV infection in solid organ transplant recipients
Transplantation Reviews, Vol. 28, Núm. 2, pp. 84-91
2012
-
New concepts and best practices for management of pre- and post-transplantation cancer
Transplantation Reviews, Vol. 26, Núm. 4, pp. 261-279